ACHV (Achieve Life Sciences Inc) Bozor qiymatining balans qiymatiga nisbati

Achieve Life Sciences, Inc (ACHV) - korporativ logo

Achieve Life Sciences (ACHV) kompaniyasining vizuallashtirilgan narxlar dinamikasi chekishni tashlash vositalarini ishlab chiqishda ESG tamoyillari va bioetikani integratsiya qilayotgan biznesga nisbatan bozor kutganlarini aks ettiradi. Joriy ko'rsatkich -48.74 darajasida turibdi, xatarlar esa likvidlik cheklovlari va AQSh tartibga soluvchi organlarining kutilayotgan qaroriga bog'liq. O'sish istiqbollari dori vositasining noyob o'simliklar asosidagi tarkibiga va sog'lom turmush tarziga bo'lgan global tendentsiyaga tayanadi.

Achieve Life Sciences (ACHV) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha
Achieve Life Sciences, Inc tayyor mahsulotlari

Achieve Life Sciences (ACHV) aktivlarining sifatini baholashda, biznesning sof qiymatiga nisbatan bozor diskonti yoki premiumining darajasini tushunish muhimdir. GURU.Markets platformasida balans hisobotidagi kapitalning qayta baholash darajasidagi o'zgarishlarni tahlil qilish orqali investor bozor qiymatining moddiy aktivlarga nisbatini aniqlashi mumkin, bu esa makrotsikllar davomida barqaror qoladigan Achieve Life Sciences (ACHV) kabi emitent uchun investitsiyalarning himoyalanganligi va fundamental kapital barqarorligining ko'rsatkichi bo'lib xizmat qiladi.

Raqobatchilar tahlili

Indivior PLC (INDV) - Kapitallashuvning sof aktivlarga nisbati|COLL (collegiumpharma.com) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Cronos Group (CRON)|Kapitallashuvning balans qiymatiga nisbati Canopy Growth Corp|Bozor kapitallashuvining balans qiymatiga nisbati HITI|Bozor kapitallashuvining balans qiymatiga nisbati ACB (auroramj.com)|Bozor qiymatining balans qiymatiga nisbati Skye Bioscience, Inc.|Balans qiymatiga nisbatan bozor qiymati anebulo.com ANEB|INCR: Bozor kapitallashuvining balans qiymatiga nisbati|NTRB: Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati NSRX|Bozor qiymatining balans qiymatiga koeffitsiyenti IGC Pharma|MIRA - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati floragrowth.ca|IMCC - Bozor kapitallashuvining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi adialpharma.com (ADIL)|Bozor kapitallashuvining balans qiymatiga nisbati ARTL (Artelo Biosciences, Inc.)|Ensysce Biosciences Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Titan Pharma (TTNP)|GNLN: Balans qiymatiga nisbatan bozor qiymati|INM (InMed Pharmaceuticals Inc.) - Bozor qiymatining balans qiymatiga nisbati|Akanda Corp (AKAN) - Kapitallashuvning sof aktivlarga nisbati|ENVB (Enveric) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Bright Green Corp|Bozor kapitallashuvining balans qiymatiga nisbati HPCO (Hempacco)